SCHEMBL9867241

SCHEMBL9867241

CC(C)(Cc1ccc(-c2nsc(S(N)(=O)=O)n2)cc1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.38
BLM P54132 2/20 0.38
SMN1; SMN2 Q16637 5/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
LMNA P02545 3/20 0.37
POLB P06746 2/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SLC22A12 Q96S37 1/20 0.36
CYP19A1 P11511 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
EGFR P00533 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867513 0.80 ADORA3 (0.36) CYP2C9SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL9868097 0.75 CYP19A1 (0.58) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL9865836 0.73 CA2 (0.55) CA2
SCHEMBL9866053 0.73 CA2 (0.43) CYP19A1MEN1KMT2AALDH1A1KDM4E
SCHEMBL9867816 0.73 HSD17B1 (0.46) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL9867067 0.73 ADORA3 (0.56) SMN1; SMN2NPC1RAB9ALMNAPOLB
SCHEMBL10976295 0.72 CA2 (0.57) LMNAKMT2AKDM4ETDP1CA1
SCHEMBL10913248 0.72 CA2 (0.54) CA1CA2CA12CA9CA14
SCHEMBL9866328 0.70 NPC1 (0.49) SMN1; SMN2NPC1RAB9ALMNAPOLB
SCHEMBL9869169 0.70 CA2 (0.47) LMNATP53CYP19A1MAPTPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US disclosed